Giant cell arteritis

Autoimmunity Reviews

Volumn 2, Issue 4, 2003, Pages 199-203

  Penn, Henry ^a   Dasgupta, Bhaskar ^a  

^a SOUTHEND UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Giant cell arteritis; Rheumatic disease; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; TUMOR NECROSIS FACTOR; VITAMIN D;

AMINO ACID SEQUENCE; ANTIBODY COMBINING SITE; ARTERY INJURY; BLOOD VESSEL BIOPSY; CLINICAL FEATURE; DRUG ACCUMULATION; DRUG DOSE REDUCTION; FAMILIAL DISEASE; GENE CLUSTER; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GIANT CELL ARTERITIS; GRANULOMATOUS INFLAMMATION; HEADACHE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOPATHOGENESIS; OPHTHALMOSCOPY; REVIEW; TEMPORAL ARTERY; VISUAL IMPAIRMENT;

EID: 0038387881     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(03)00012-0     Document Type: Review

References (15)

1. Hamilton C.R., Shelley W.M., Tumulty P.A. Giant cell arteritis and polymyalgia rheumatica. Medicine. 50:1971;1-27.
2. Horton BT, Magath TB, Brown GE. An undescribed form of arteritis of temporal vessels. Proceedings of the Staff Meetings of the Mayo Clinic, 1932. p. 7700-7701.
3. Duhaut P., Bosshard S., Dumontet C. Giant cell arteritis and polymyalgia rheumatica: role of viral infections. Clin Exp Rheumatol. 18:2000;S22-S23.
4. Weyand C.M., Goronzy J.J. Arterial wall injury in giant cell arteritis. Arthritis Rheum. 42:1999;844-853.
5. Dababneh A., Gonzalez-Gay M.A., Garcia-Porrua C., Hajeer A., Thomson W., Ollier W. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J Rheumatol. 25:1998;2140-2145.
6. Liozin E., Roblot P., Paire D., et al. Anticardiolipin antibody levels predict flares and relapses in patients with giant cell arteritis A longitudinal study of 58 biopsy proven cases. Rheumatology. 39:(10):2000;1089-1094.
7. Kaiser M., Younge B., et al. Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am J Pathol. 155:1999;765-774.
8. Weyand C.M., Goronzy J.J. The pathogenesis of giant cell arteritis. Bull Rheum Dis. 51:(8):2002;111.
9. Kaiser M., Weyand C.M., et al. Platelet derived growth factor, intimal hyperplasia, and ischaemic complications in giant cell arteritis. Arthritis Rheum. 41:1998;623-633.
10. Weyand C.M., Hicok K.C., Hunder G.G., Goronzy J.J. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med. 121:1994;484-491.
11. Weyand C.M., et al. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum. 40:1997;19-26.
12. Hunder G.G., Bloch D.A., Michael B.A., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 33:1990;1122.
13. Hoffman G.S., Cid M.C., Hellmann D.B., et al. A multi-center, randomised, double blind, placebo controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 46:(5):2002;1309-1318.
14. Jover J.A., Hetrnandez-Garcia C., Morado I.C., et al. Combined treatment of giant cell arteritis with methotrexate and prednisolone: a randomised, double blind, placebo-controlled trial. Annals Int Med. 134:(2):2001;106-114.
15. Weyand C.M., Kaiser M., Yang H., et al. Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum. 46:2002;457-466.